Human placental growth hormone in normal and abnormal fetal growth (Review)
- Authors:
- Alexandros Velegrakis
- Maria Sfakiotaki
- Stavros Sifakis
-
Affiliations: Department of Obstetrics and Gynecology, Venizelion General Hospital, Heraklion 71409, Greece, Department of Endocrinology, University Hospital of Heraklion, Heraklion 71201, Greece, Department of Obstetrics and Gynecology, University Hospital of Heraklion, Heraklion 71201, Greece - Published online on: June 21, 2017 https://doi.org/10.3892/br.2017.930
- Pages: 115-122
-
Copyright: © Velegrakis et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
|
Fuglsang J and Ovesen P: Aspects of placental growth hormone physiology. Growth Horm IGF Res. 16:67–85. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Sifakis S, Akolekar R, Mantas N, Kappou D and Nicolaides KH: Maternal serum human placental growth hormone (hPGH) at 11 to 13 weeks of gestation in preeclampsia. Hypertens Pregnancy. 30:74–82. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Chellakooty M, Vangsgaard K, Larsen T, Scheike T, Falck-Larsen J, Legarth J, Andersson AM, Main KM, Skakkebaek NE and Juul A: A longitudinal study of intrauterine growth and the placental growth hormone (GH)-insulin-like growth factor I axis in maternal circulation: Association between placental GH and fetal growth. J Clin Endocrinol Metab. 89:384–391. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Alsat E, Guibourdenche J, Luton D, Frankenne F and Evain-Brion D: Human placental growth hormone. Am J Obstet Gynecol. 177:1526–1534. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Caufriez A, Frankenne F, Englert Y, Golstein J, Cantraine F, Hennen G and Copinschi G: Placental growth hormone as a potential regulator of maternal IGF-I during human pregnancy. Am J Physiol. 258:E1014–E1019. 1990.PubMed/NCBI | |
|
Caufriez A, Frankenne F, Hennen G and Copinschi G: Regulation of maternal IGF-I by placental GH in normal and abnormal human pregnancies. Am J Physiol. 265:E572–E577. 1993.PubMed/NCBI | |
|
Vatten LJ, Nilsen TI, Juul A, Jeansson S, Jenum PA and Eskild A: Changes in circulating level of IGF-I and IGF-binding protein-1 from the first to second trimester as predictors of preeclampsia. Eur J Endocrinol. 158:101–105. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Lacroix MC, Guibourdenche J, Fournier T, Laurendeau I, Igout A, Goffin V, Pantel J, Tsatsaris V and Evain-Brion D: Stimulation of human trophoblast invasion by placental growth hormone. Endocrinology. 146:2434–2444. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lacroix MC, Bolifraud P, Durieux D, Pauloin A, Vidaud M and Kann G: Placental growth hormone and lactogen production by perifused ovine placental explants: Regulation by growth hormone-releasing hormone and glucose. Biol Reprod. 66:555–561. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Takata K, Kasahara T, Kasahara M, Ezaki O and Hirano H: Localization of erythrocyte/HepG2-type glucose transporter (GLUT1) in human placental villi. Cell Tissue Res. 267:407–412. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Barbour LA, Shao J, Qiao L, Pulawa LK, Jensen DR, Bartke A, Garrity M, Draznin B and Friedman JE: Human placental growth hormone causes severe insulin resistance in transgenic mice. Am J Obstet Gynecol. 186:512–517. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
McIntyre HD, Serek R, Crane DI, Veveris-Lowe T, Parry A, Johnson S, Leung KC, Ho KK, Bougoussa M, Hennen G, et al: Placental growth hormone (GH), GH-binding protein, and insulin-like growth factor axis in normal, growth-retarded, and diabetic pregnancies: Correlations with fetal growth. J Clin Endocrinol Metab. 85:1143–1150. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Frankenne F, Alsat E, Scippo ML, Igout A, Hennen G and Evain-Brion D: Evidence for the expression of growth hormone receptors in human placenta. Biochem Biophys Res Commun. 182:481–486. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Harper ME, Barrera-Saldaña HA and Saunders GF: Chromosomal localization of the human placental lactogen-growth hormone gene cluster to 17q22-24. Am J Hum Genet. 34:227–234. 1982.PubMed/NCBI | |
|
Handwerger S and Freemark M: The roles of placental growth hormone and placental lactogen in the regulation of human fetal growth and development. J Pediatr Endocrinol Metab. 13:343–356. 2000. View Article : Google Scholar : PubMed/NCBI | |
|
Freemark M, Fleenor D, Driscoll P, Binart N and Kelly P: Body weight and fat deposition in prolactin receptor-deficient mice. Endocrinology. 142:532–537. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
George DL, Phillips JA III, Francke U and Seeburg PH: The genes for growth hormone and chorionic somatomammotropin are on the long arm of human chromosome 17 in region q21 to qter. Hum Genet. 57:138–141. 1981. View Article : Google Scholar : PubMed/NCBI | |
|
Struman I, Bentzien F, Lee H, Mainfroid V, D'Angelo G, Goffin V, Weiner RI and Martial JA: Opposing actions of intact and N-terminal fragments of the human prolactin/growth hormone family members on angiogenesis: An efficient mechanism for the regulation of angiogenesis. Proc Natl Acad Sci USA. 96:1246–1251. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Nachtigal MW, Nickel BE and Cattini PA: Pituitary-specific repression of placental members of the human growth hormone gene family. A possible mechanism for locus regulation. J Biol Chem. 268:8473–8479. 1993.PubMed/NCBI | |
|
Lacroix MC, Guibourdenche J, Frendo JL, Muller F and Evain-Brion D: Human placental growth hormone - a review. Placenta. 23 Suppl A:S87–S94. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Silva CM, Kloth MT, Lyons CE, Dunn CR and Kirk SE: Intracellular signaling by growth hormone variant (GH-V). Growth Horm IGF Res. 12:374–380. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Cacciari E, Pirazzoli P, Gualandi S, Baroncini C, Baldazzi L, Trevisani B, Capelli M, Zucchini S, Balsamo A, Cicognani A, et al: Molecular study of human growth hormone gene cluster in three families with isolated growth hormone deficiency and similar phenotype. Eur J Pediatr. 153:635–641. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Mullis PE, Akinci A, Kanaka C, Eblé A and Brook CG: Prevalence of human growth hormone-1 gene deletions among patients with isolated growth hormone deficiency from different populations. Pediatr Res. 31:532–534. 1992. View Article : Google Scholar : PubMed/NCBI | |
|
Frankenne F, Closset J, Gomez F, Scippo ML, Smal J and Hennen G: The physiology of growth hormones (GHs) in pregnant women and partial characterization of the placental GH variant. J Clin Endocrinol Metab. 66:1171–1180. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Frankenne F, Scippo ML, van Beeumen J, Igout A and Hennen G: Identification of placental human growth hormone as the growth hormone-V gene expression product. J Clin Endocrinol Metab. 71:15–18. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Nickel BE, Kardami E and Cattini PA: The human placental growth hormone variant is mitogenic for rat lymphoma Nb2 cells. Endocrinology. 126:971–976. 1990. View Article : Google Scholar : PubMed/NCBI | |
|
Cooke NE, Ray J, Emery JG and Liebhaber SA: Two distinct species of human growth hormone-variant mRNA in the human placenta predict the expression of novel growth hormone proteins. J Biol Chem. 263:9001–9006. 1988.PubMed/NCBI | |
|
Selden RF, Wagner TE, Blethen S, Yun JS, Rowe ME and Goodman HM: Expression of the human growth hormone variant gene in cultured fibroblasts and transgenic mice. Proc Natl Acad Sci USA. 85:8241–8245. 1988. View Article : Google Scholar : PubMed/NCBI | |
|
Ghizzoni L, Duquesnoy P, Torresani T, Vottero A, Goossens M and Bernasconi S: Isolated growth hormone deficiency type IA associated with a 45-kilobase gene deletion within the human growth hormone gene cluster in an Italian family. Pediatr Res. 36:654–659. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Mirlesse V, Frankenne F, Alsat E, Poncelet M, Hennen G and Evain-Brion D: Placental growth hormone levels in normal pregnancy and in pregnancies with intrauterine growth retardation. Pediatr Res. 34:439–442. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Moghadam S, Engel W, Bougoussa M, Hennen G, Igout A and Sancken U: Maternal serum placental growth hormone and insulinlike growth factor binding proteins 1 and 3 in pregnancies affected by fetal aneuploidy and other abnormalities: Implications for prenatal diagnosis of trisomy 21. Fetal Diagn Ther. 13:291–297. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Curran AJ, Peacey SR and Shalet SM: Is maternal growth hormone essential for a normal pregnancy? Eur J Endocrinol. 139:54–58. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Papadopoulou E, Sifakis S, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E and Kalmanti M: Human placental growth hormone is increased in maternal serum in pregnancies affected by Down syndrome. Fetal Diagn Ther. 23:211–216. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Freemark M: Regulation of maternal metabolism by pituitary and placental hormones: Roles in fetal development and metabolic programming. Horm Res. 65 Suppl 3:41–49. 2006.PubMed/NCBI | |
|
Ray J, Okamura H, Kelly PA, Cooke NE and Liebhaber SA: Human growth hormone-variant demonstrates a receptor binding profile distinct from that of normal pituitary growth hormone. J Biol Chem. 265:7939–7944. 1990.PubMed/NCBI | |
|
Gootwine E: Placental hormones and fetal-placental development. Anim Reprod Sci 82–83. 1–566. 2004. | |
|
Schock H, Zeleniuch-Jacquotte A, Lundin E, Grankvist K, Lakso HÅ, Idahl A, Lehtinen M, Surcel HM and Fortner RT: Hormone concentrations throughout uncomplicated pregnancies: A longitudinal study. BMC Pregnancy Childbirth. 16:1462016. View Article : Google Scholar : PubMed/NCBI | |
|
Walker WH, Fitzpatrick SL, Barrera-Saldaña HA, Resendez-Perez D and Saunders GF: The human placental lactogen genes: Structure, function, evolution and transcriptional regulation. Endocr Rev. 12:316–328. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Freemark M: Placental hormones and the control of fetal growth. J Clin Endocrinol Metab. 95:2054–2057. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
MacLeod JN, Worsley I, Ray J, Friesen HG, Liebhaber SA and Cooke NE: Human growth hormone-variant is a biologically active somatogen and lactogen. Endocrinology. 128:1298–1302. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Wu Z, Bidlingmaier M, Friess SC, Kirk SE, Buchinger P, Schiessl B and Strasburger CJ: A new nonisotopic, highly sensitive assay for the measurement of human placental growth hormone: Development and clinical implications. J Clin Endocrinol Metab. 88:804–811. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Männik J, Vaas P, Rull K, Teesalu P, Rebane T and Laan M: Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. J Clin Endocrinol Metab. 95:2433–2442. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Ursell W, Brudenell M and Chard T: Placental lactogen levels in diabetic pregnancy. BMJ. 2:80–82. 1973. View Article : Google Scholar : PubMed/NCBI | |
|
Langford KS, Nicolaides KH, Jones J, Abbas A, McGregor AM and Miell JP: Serum insulin-like growth factor-binding protein-3 (IGFBP-3) levels and IGFBP-3 protease activity in normal, abnormal, and multiple human pregnancy. J Clin Endocrinol Metab. 80:21–27. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Reece EA, Wiznitzer A, Le E, Homko CJ, Behrman H and Spencer EM: The relation between human fetal growth and fetal blood levels of insulin-like growth factors I and II, their binding proteins, and receptors. Obstet Gynecol. 84:88–95. 1994.PubMed/NCBI | |
|
Coutant R, de Casson F Boux, Douay O, Mathieu E, Rouleau S, Beringue F, Gillard P, Limal JM and Descamps P: Relationships between placental GH concentration and maternal smoking, newborn gender, and maternal leptin: Possible implications for birth weight. J Clin Endocrinol Metab. 86:4854–4859. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Boutsikou T, Malamitsi-Puchner A, Economou E, Boutsikou M, Puchner KP and Hassiakos D: Soluble vascular endothelial growth factor receptor-1 in intrauterine growth restricted fetuses and neonates. Early Hum Dev. 82:235–239. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Malamitsi-Puchner A, Boutsikou T, Economou E, Sarandakou A, Makrakis E, Hassiakos D, et al: Vascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates. Mediat Inflamm. 2005:293–297. 2005. View Article : Google Scholar | |
|
Kedzia A, Tarka A, Petriczko E, Pruski D and Iwaniec K: Placental growth hormone (PGH), pituitary growth hormone (GH1), insulin-like growth factor (IGF-I) and ghrelin in pregnant women's blood serum. Ginekol Pol. 84:620–623. 2013. View Article : Google Scholar : PubMed/NCBI | |
|
Pedersen NG, Juul A, Christiansen M, Wøjdemann KR and Tabor A: Maternal serum placental growth hormone, but not human placental lactogen or insulin growth factor-1, is positively associated with fetal growth in the first half of pregnancy. Ultrasound Obstet Gynecol. 36:534–541. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Chellakooty M, Skibsted L, Skouby SO, Andersson AM, Petersen JH, Main KM, Skakkebaek NE and Juul A: Longitudinal study of serum placental GH in 455 normal pregnancies: Correlation to gestational age, fetal gender, and weight. J Clin Endocrinol Metab. 87:2734–2739. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Eriksson L, Frankenne F, Edèn S, Hennen G and Von Schoultz B: Growth hormone 24-h serum profiles during pregnancy-lack of pulsatility for the secretion of the placental variant. Br J Obstet Gynaecol. 96:949–953. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Liebhaber SA, Urbanek M, Ray J, Tuan RS and Cooke NE: Characterization and histologic localization of human growth hormone-variant gene expression in the placenta. J Clin Invest. 83:1985–1991. 1989. View Article : Google Scholar : PubMed/NCBI | |
|
Scippo ML, Frankenne F, Hooghe-Peters EL, Igout A, Velkeniers B and Hennen G: Syncytiotrophoblastic localization of the human growth hormone variant mRNA in the placenta. Mol Cell Endocrinol. 92:R7–R13. 1993. View Article : Google Scholar : PubMed/NCBI | |
|
Mittal P, Espinoza J, Hassan S, Kusanovic JP, Edwin SS, Nien JK, Gotsch F, Than NG, Erez O, Mazaki-Tovi S, et al: Placental growth hormone is increased in the maternal and fetal serum of patients with preeclampsia. J Matern Fetal Neonatal Med. 20:651–659. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Goodman HM, Tai LR, Ray J, Cooke NE and Liebhaber SA: Human growth hormone variant produces insulin-like and lipolytic responses in rat adipose tissue. Endocrinology. 129:1779–1783. 1991. View Article : Google Scholar : PubMed/NCBI | |
|
Street ME, Seghini P, Fieni S, Ziveri MA, Volta C, Martorana D, Viani I, Gramellini D and Bernasconi S: Changes in interleukin-6 and IGF system and their relationships in placenta and cord blood in newborns with fetal growth restriction compared with controls. Eur J Endocrinol. 155:567–574. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Street ME, Seghini P, Ziveri MA, Fieni S, Volta C, Neri TM, Viani I, Bacchi-Modena A and Bernasconi S: Interleukin-6 and insulin-like growth factor system relationships and differences in the human placenta and fetus from the 35th week of gestation. Growth Horm IGF Res. 16:365–372. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Fowden AL and Forhead AJ: Endocrine regulation of feto-placental growth. Horm Res. 72:257–265. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Handwerger S: The growth hormone gene cluster: Physiological actions and regulation during pregnancy. Growth Genet Horm. 25:1–8. 2009. | |
|
Rechler MM and Clemmons DR: Regulatory Actions of Insulin-like Growth Factor-binding Proteins. Trends Endocrinol Metab. 9:176–183. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Freemark M, Avril I, Fleenor D, Driscoll P, Petro A, Opara E, Kendall W, Oden J, Bridges S, Binart N, et al: Targeted deletion of the PRL receptor: Effects on islet development, insulin production, and glucose tolerance. Endocrinology. 143:1378–1385. 2002. View Article : Google Scholar : PubMed/NCBI | |
|
Fleenor D, Oden J, Kelly PA, Mohan S, Alliouachene S, Pende M, Wentz S, Kerr J and Freemark M: Roles of the lactogens and somatogens in perinatal and postnatal metabolism and growth: Studies of a novel mouse model combining lactogen resistance and growth hormone deficiency. Endocrinology. 146:103–112. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
McDonald EA and Wolfe MW: Adiponectin attenuation of endocrine function within human term trophoblast cells. Endocrinology. 150:4358–4365. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Arumugam R, Fleenor D and Freemark M: Effects of lactogen resistance and GH deficiency on mouse metabolism: Pancreatic hormones, adipocytokines, and expression of adiponectin and insulin receptors. Endocrine. 32:182–191. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Wallner W, Sengenberger R, Strick R, Strissel PL, Meurer B, Beckmann MW and Schlembach D: Angiogenic growth factors in maternal and fetal serum in pregnancies complicated by intrauterine growth restriction. Clin Sci (Lond). 112:51–57. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Christiansen M: Placental growth hormone and growth hormone binding protein are first trimester maternal serum markers of Down syndrome. Prenat Diagn. 29:1249–1255. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Fisker S, Ebdrup L and Orskov H: Influence of growth hormone binding protein on growth hormone estimation in different immunoassays. Scand J Clin Lab Invest. 58:373–381. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Baviera G, Carbone C, Corrado F and Mastrantonio P: Placental growth hormone in Down's syndrome screening. J Matern Fetal Neonatal Med. 16:241–243. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Leung TY, Chan LW, Leung TN, Fung TY, Sahota DS and Lau TK: First-trimester maternal serum levels of placental hormones are independent predictors of second-trimester fetal growth parameters. Ultrasound Obstet Gynecol. 27:156–161. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Sifakis S, Papadopoulou E, Konstantinidou A, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E and Kalmanti M: Increased levels of human placental growth hormone in the amniotic fluid of pregnancies affected by Down syndrome. Growth Horm IGF Res. 19:121–125. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Sifakis S, Akolekar R, Syngelaki A, De Cruz J and Nicolaides KH: Maternal serum human placental growth hormone at 11 to 13 weeks in trisomy 21 and trisomy 18 pregnancies. Prenat Diagn. 30:212–215. 2010.PubMed/NCBI | |
|
Alldred SK, Takwoingi Y, Guo B, Pennant M, Deeks JJ, Neilson JP and Alfirevic Z: First trimester serum tests for Down's syndrome screening. Cochrane Database Syst Rev. 11:CD0119752015. | |
|
Verhaeghe J: Does the physiological acromegaly of pregnancy benefit the fetus? Gynecol Obstet Invest. 66:217–226. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Chaiworapongsa T, Romero R, Espinoza J, Bujold E, Mee Kim Y, Gonçalves LF, Gomez R and Edwin S: Evidence supporting a role for blockade of the vascular endothelial growth factor system in the pathophysiology of preeclampsia. Young Investigator Award. Am J Obstet Gynecol. 190:1541–1547, discussion 1547–1550. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Koga K, Osuga Y, Yoshino O, Hirota Y, Ruimeng X, Hirata T, Takeda S, Yano T, Tsutsumi O and Taketani Y: Elevated serum soluble vascular endothelial growth factor receptor 1 (sVEGFR-1) levels in women with preeclampsia. J Clin Endocrinol Metab. 88:2348–2351. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Maynard SE, Min JY, Merchan J, Lim KH, Li J, Mondal S, Libermann TA, Morgan JP, Sellke FW, Stillman IE, et al: Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest. 111:649–658. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
McKeeman GC, Ardill JE, Caldwell CM, Hunter AJ and McClure N: Soluble vascular endothelial growth factor receptor-1 (sFlt-1) is increased throughout gestation in patients who have preeclampsia develop. Am J Obstet Gynecol. 191:1240–1246. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Evain-Brion D: Hormonal regulation of fetal growth. Horm Res. 42:207–214. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Papadopoulou E, Sifakis S, Giahnakis E, Fragouli Y, Karkavitsas N, Koumantakis E and Kalmanti M: Increased human placental growth hormone at midtrimester pregnancies may be an index of intrauterine growth retardation related to preeclampsia. Growth Horm IGF Res. 16:290–296. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Chaiworapongsa T, Romero R, Kim YM, Kim GJ, Kim MR, Espinoza J, Bujold E, Gonçalves L, Gomez R, Edwin S, et al: Plasma soluble vascular endothelial growth factor receptor-1 concentration is elevated prior to the clinical diagnosis of pre-eclampsia. J Matern Fetal Neonatal Med. 17:3–18. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Crispi F, Domínguez C, Llurba E, Martín-Gallán P, Cabero L and Gratacós E: Placental angiogenic growth factors and uterine artery Doppler findings for characterization of different subsets in preeclampsia and in isolated intrauterine growth restriction. Am J Obstet Gynecol. 195:201–207. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Rajakumar A, Michael HM, Rajakumar PA, Shibata E, Hubel CA, Karumanchi SA, Thadhani R, Wolf M, Harger G and Markovic N: Extra-placental expression of vascular endothelial growth factor receptor-1, (Flt-1) and soluble Flt-1 (sFlt-1), by peripheral blood mononuclear cells (PBMCs) in normotensive and preeclamptic pregnant women. Placenta. 26:563–573. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Evain-Brion D, Alsat E, Igout A, Frankenne F and Hennen G: Placental growth hormone variant: Assay and clinical aspects. Acta Paediatr Suppl. 399(s399): 49–51; discussion 52. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Kupferminc MJ, Daniel Y, Englender T, Baram A, Many A, Jaffa AJ, Gull I and Lessing JB: Vascular endothelial growth factor is increased in patients with preeclampsia. Am J Reprod Immunol. 38:302–306. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Krauss T, Pauer HU and Augustin HG: Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia. Hypertens Pregnancy. 23:101–111. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Levine RJ and Karumanchi SA: Circulating angiogenic factors in preeclampsia. Clin Obstet Gynecol. 48:372–386. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Levine RJ, Lam C, Qian C, Yu KF, Maynard SE, Sachs BP, Sibai BM, Epstein FH, Romero R, Thadhani R, et al: CPEP Study Group: Soluble endoglin and other circulating antiangiogenic factors in preeclampsia. N Engl J Med. 355:992–1005. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Levine RJ, Maynard SE, Qian C, Lim KH, England LJ, Yu KF, Schisterman EF, Thadhani R, Sachs BP, Epstein FH, et al: Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med. 350:672–683. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Levine RJ, Thadhani R, Qian C, Lam C, Lim KH, Yu KF, Blink AL, Sachs BP, Epstein FH, Sibai BM, et al: Urinary placental growth factor and risk of preeclampsia. JAMA. 293:77–85. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Lyall F, Greer IA, Boswell F and Fleming R: Suppression of serum vascular endothelial growth factor immunoreactivity in normal pregnancy and in pre-eclampsia. Br J Obstet Gynaecol. 104:223–228. 1997. View Article : Google Scholar : PubMed/NCBI | |
|
Robinson CJ, Johnson DD, Chang EY, Armstrong DM and Wang W: Evaluation of placenta growth factor and soluble Fms-like tyrosine kinase 1 receptor levels in mild and severe preeclampsia. Am J Obstet Gynecol. 195:255–259. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Staff AC, Braekke K, Harsem NK, Lyberg T and Holthe MR: Circulating concentrations of sFlt1 (soluble fms-like tyrosine kinase 1) in fetal and maternal serum during pre-eclampsia. Eur J Obstet Gynecol Reprod Biol. 122:33–39. 2005. View Article : Google Scholar : PubMed/NCBI | |
|
Thadhani R, Mutter WP, Wolf M, Levine RJ, Taylor RN, Sukhatme VP, Ecker J and Karumanchi SA: First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia. J Clin Endocrinol Metab. 89:770–775. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Torry DS, Wang HS, Wang TH, Caudle MR and Torry RJ: Preeclampsia is associated with reduced serum levels of placenta growth factor. Am J Obstet Gynecol. 179:1539–1544. 1998. View Article : Google Scholar : PubMed/NCBI | |
|
Venkatesha S, Toporsian M, Lam C, Hanai J, Mammoto T, Kim YM, Bdolah Y, Lim KH, Yuan HT, Libermann TA, et al: Soluble endoglin contributes to the pathogenesis of preeclampsia. Nat Med. 12:642–649. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Zhou Y, McMaster M, Woo K, Janatpour M, Perry J, Karpanen T, Alitalo K, Damsky C and Fisher SJ: Vascular endothelial growth factor ligands and receptors that regulate human cytotrophoblast survival are dysregulated in severe preeclampsia and hemolysis, elevated liver enzymes, and low platelets syndrome. Am J Pathol. 60:1405–1423. 2002. View Article : Google Scholar | |
|
Koutsaki M, Sifakis S, Zaravinos A, Koutroulakis D, Koukoura O and Spandidos DA: Decreased placental expression of hPGH, IGF-I and IGFBP-1 in pregnancies complicated by fetal growth restriction. Growth Horm IGF Res. 21:31–36. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Sifakis S, Akolekar R, Kappou D, Mantas N and Nicolaides KH: Maternal serum placental growth hormone at 11–13 weeks' gestation in pregnancies delivering small for gestational age neonates. J Matern Fetal Neonatal Med. 25:1796–1799. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Hu L, Lytras A, Bock ME, Yuen CK, Dodd JG and Cattini PA: Detection of placental growth hormone variant and chorionic somatomammotropin-L RNA expression in normal and diabetic pregnancy by reverse transcriptase-polymerase chain reaction. Mol Cell Endocrinol. 157:131–142. 1999. View Article : Google Scholar : PubMed/NCBI | |
|
Eleftheriades M, Papastefanou I, Lambrinoudaki I, Kappou D, Lavranos D, Akalestos A, Souka AP, Pervanidou P, Hassiakos D and Chrousos GP: Elevated placental growth factor concentrations at 11–14 weeks of gestation to predict gestational diabetes mellitus. Metabolism. 63:1419–1425. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Higgins MF, Russell NE, Crossey PA, Nyhan KC, Brazil DP and McAuliffe FM: Maternal and fetal placental growth hormone and IGF axis in type 1 diabetic pregnancy. PLoS One. 7:e291642012. View Article : Google Scholar : PubMed/NCBI | |
|
Fuglsang J, Lauszus F, Flyvbjerg A and Ovesen P: Human placental growth hormone, insulin-like growth factor I and -II, and insulin requirements during pregnancy in type 1 diabetes. J Clin Endocrinol Metab. 88:4355–4361. 2003. View Article : Google Scholar | |
|
Ringholm L, Juul A, Pedersen-Bjergaard U, Thorsteinsson B, Damm P and Mathiesen ER: Lower levels of placental growth hormone in early pregnancy in women with type 1 diabetes and large for gestational age infants. Growth Horm IGF Res. 25:312–315. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
McIntyre HD, Zeck W and Russell A: Placental growth hormone, fetal growth and the IGF axis in normal and diabetic pregnancy. Curr Diabetes Rev. 5:185–189. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schock H, Fortner RT, Surcel HM, Grankvist K, Pukkala E, Lehtinen M and Lundin E: Early pregnancy IGF-I and placental GH and risk of epithelial ovarian cancer: A nested case-control study. Int J Cancer. 137:439–447. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Hübener C, Bidlingmaier M, Wu Z, Diebold J, Delius M, Friese K, Strasburger CJ and Hasbargen U: Human placental growth hormone: A potential new biomarker in gestational trophoblastic disease. Gynecol Oncol. 136:264–268. 2015. View Article : Google Scholar : PubMed/NCBI |
